Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

Szczegóły

Tytuł:: Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?
Autorzy:: Di Maio VC; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Cento V; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Aragri M; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Paolucci S; Molecular Virology, Policlinic Foundation San Matteo, Pavia, Italy.
Pollicino T; Department of Internal Medicine, University Hospital of Messina, Messina, Italy.
Coppola N; Infectious Diseases and Viral Hepatitis Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
Bruzzone B; Hygiene Unit, IRCCS AOU San Martino-IST, Genoa, Italy.
Ghisetti V; Laboratory of Microbiology and Virology, Amedeo di Savoia Hospital, ASL Città di Torino, Turin, Italy.
Zazzi M; Virology, Siena University Hospital, Siena, Italy.
Brunetto M; Hepatology Unit and Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses - University Hospital of Pisa, Italy.
Bertoli A; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Barbaliscia S; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Galli S; Microbiology and Virology Unit, Sant'Orsola-Malpighi Hospital-Bologna, Italy.
Gennari W; Microbiology Laboratory, University Hospital, Modena, Italy.
Baldanti F; Molecular Virology, Policlinic Foundation San Matteo, Pavia, Italy.
Raimondo G; Department of Internal Medicine, University Hospital of Messina, Messina, Italy.
Perno CF; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Ceccherini-Silberstein F; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy. Electronic address: .
Corporate Authors:: HCV Virology Italian Resistance Network (VIRONET-C)
Źródło:: Journal of hepatology [J Hepatol] 2018 Mar; Vol. 68 (3), pp. 597-600. Date of Electronic Publication: 2017 Sep 20.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Publication: 2001- : Amsterdam : Elsevier
Original Publication: Copehnagen : Munksgaard International Publishers, [c1984-
MeSH Terms:: Antiviral Agents*/classification
Antiviral Agents*/pharmacology
Hepacivirus*/drug effects
Hepacivirus*/genetics
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/virology
Retreatment/*methods
Drug Resistance, Viral ; Humans ; Treatment Outcome
Contributed Indexing:: Investigator: P Andreone; M Andreoni; M Angelico; S Babudieri; G Barbarini; V Boccaccio; L Boglione; M Bolis; S Bonora; V Borghi; G Brancaccio; S Bruno; P Cacciatore; V Calvaruso; N Caporaso; A Ciaccio; A Ciancio; P Colombatto; R Cozzolongo; A Craxì; C D'Ambrosio; G D'Ettorre; A De Luca; A Di Biagio; G Di Perri; S Francioso; GB Gaeta; A Giorgini; A Grieco; G Gubertini; R Gulminetti; L Lambiase; I Lenci; M Lichtner; I Maida; S Marenco; L Marinaro; R Maserati; C Masetti; M Melis; E Meregalli; V Micheli; F Morisco; F Niero; LA Nicolini; VP Palitti; M Paoloni; G Parruti; C Pasquazzi; A Pellicelli; E Polilli; ML Ponti; M Puoti; M Rendina; G Rizzardini; B Rossetti; T Ruggiero; V Sangiovanni; M Starace; L Sticchi; P Tarquini; P Toniutto; V Vullo
Substance Nomenclature:: 0 (Antiviral Agents)
Entry Date(s):: Date Created: 20170924 Date Completed: 20190628 Latest Revision: 20190628
Update Code:: 20240104
DOI:: 10.1016/j.jhep.2017.09.008
PMID:: 28939133
: Raport

Full Text Finder

Informacja